The Pediatric Praziquantel Consortium says it has achieved a milestone by administering arpraziquantel to the first preschool-aged child for the treatment of schistosomiasis, otherwise known as snail fever. It was disclosed that Uganda became the first country to introduce arpraziquantel to children under five, marking a significant step toward expanding treatment access. According to a